Nevertheless, the convergence of (i) higher baseline CRP among improvers, (ii) the strong correlation with CRP/NLR and MELD, and (iii) the recognised role of glutathione in modulating redox-sensitive inflammatory pathways, does support a biologically coherent hypothesis: glutathione may be most useful in patients with an inflammatory phenotype, where oxidative stress and systemic inflammation are dominant, modifiable drivers of acute decompensation (Vairetti et al., 2021)
This benefit is particularly valuable for those with melasma or post-inflammatory hyperpigmentation, offering a non-invasive alternative to harsher treatments
Genes associated with tissue repair, antioxidant defense, and anti-inflammatory pathways are upregulated
A subject should be fully acclimated to one peptide, with dosages stabilized and side effects understood, before even considering the introduction of a second